Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorIntervention: Dietary Supplement: Lactobacillus rhamnosus GGSponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chronic Myeloproliferative Neoplasm | Hematology | Leukemia | Lymphoma | Myelodysplastic Syndrome | Neuroblastoma | Neurology | Nutrition | Research | Stem Cell Therapy | Stem Cells | Transplants